RBC Capital reiterates Pfizer stock Underperform rating on product headwinds

RBC Capital reiterates Pfizer stock Underperform rating on product headwinds  Investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.